Needham & Company downgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Underperform, saying positive revenue growth may be a year ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE